Annual EBITDA
$1.68B$203.00M-10.76%
Summary
- Current Value
- As of today, BAX annual EBITDA is $1.68B, down -10.76% on
- Historical Performance
- BAX annual EBITDA is down -43.36% over the past 3 years, and down -37.56% over the past 5 years
- All-Time High Comparison
- BAX annual EBITDA is currently -57.15% below its historical high of $3.93B set on
- 3-Year Low Comparison
- BAX annual EBITDA is at its 3-year low
- Sector Comparison
- BAX annual EBITDA is higher than 95.56% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.68B | -10.8% | -43.4% | -37.6% | -52.5% | |
| Quarterly EBITDA | $431.00M | +44.6% | -38.9% | -39.8% | -54.7% | |
| TTM EBITDA | $1.73B | +1.8% | -42.6% | -36.2% | -53.2% | |
| Price | $19.73 | -39.8% | -57.1% | -74.3% | -25.3% | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $10.64B | +2.7% | -16.8% | -6.4% | -15.3% | |
| Annual EPS | -$1.27 | -184.9% | -150.3% | -166.0% | -135.4% | |
| $687.00M | -23.9% | -67.0% | -64.0% | -76.4% | ||
| Annual Net Income | -$326.00M | -280.1% | -125.2% | -132.3% | -114.7% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.02B | N/A | -44.2% |
| 5Y | $3.02B | -44.2% | |
| All | $3.93B | -57.1% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.68B | at low | |
| 5Y | $1.68B | at low | |
| All | $252.40M | +567.2% |
EBITDA History
FAQ
What is the current annual EBITDA of BAX?
As of today, BAX annual EBITDA is $1.68B
What is 1-year change in BAX annual EBITDA?
BAX annual EBITDA is down -10.76% year-over-year
What is 3-year change in BAX annual EBITDA?
BAX annual EBITDA is down -43.36% over the past 3 years
How far is BAX annual EBITDA from its all-time high?
BAX annual EBITDA is currently -57.15% below its historical high of $3.93B set on December 31, 2011
How does BAX annual EBITDA rank versus sector peers?
BAX annual EBITDA is higher than 95.56% of companies in Healthcare sector
When is BAX next annual earnings release?
The next annual earnings release for BAX is on
Quarterly EBITDA
$431.00M$21.00M-4.65%
Summary
- Current Value
- As of today, BAX quarterly EBITDA is $431.00M, down -4.65% on
- Historical Performance
- BAX quarterly EBITDA is up +44.63% year-over-year, and down -38.87% over the past 3 years
- All-Time High Comparison
- BAX quarterly EBITDA is currently -74.77% below its historical high of $1.71B set on
- 3-Year Low Comparison
- BAX quarterly EBITDA is +44.63% above its 3-year low of $298.00M reached on
- Sector Comparison
- BAX quarterly EBITDA is higher than 95.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $431.00M | -4.7% | +44.6% | -38.9% | -39.8% | |
| Annual EBITDA | $1.68B | – | -10.8% | -43.4% | -37.6% | |
| TTM EBITDA | $1.73B | +8.3% | +1.8% | -42.6% | -36.2% | |
| Price | $19.73 | -12.0% | -39.8% | -57.1% | -74.3% | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $2.84B | +0.9% | +5.0% | -21.4% | -4.6% | |
| Quarterly EPS | $0.02 | -92.0% | -93.6% | +100.3% | -97.5% | |
| $189.00M | -3.1% | +11.8% | -49.5% | -62.7% | ||
| Quarterly Net Income | -$51.00M | -141.8% | -183.6% | +98.3% | -114.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $452.00M | -4.7% | |
| 3Y | $928.00M | N/A | -53.6% |
| 5Y | $928.00M | -53.6% | |
| All | $1.71B | -74.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $419.00M | N/A | +2.9% |
| 3Y | $298.00M | +44.6% | |
| 5Y | $298.00M | +44.6% | |
| All | -$4.29B | +110.0% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of BAX?
As of today, BAX quarterly EBITDA is $431.00M
What is BAX quarterly EBITDA most recent change?
BAX quarterly EBITDA was down -4.65% on September 30, 2025
What is 1-year change in BAX quarterly EBITDA?
BAX quarterly EBITDA is up +44.63% year-over-year
How far is BAX quarterly EBITDA from its all-time high?
BAX quarterly EBITDA is currently -74.77% below its historical high of $1.71B set on September 30, 1988
How does BAX quarterly EBITDA rank versus sector peers?
BAX quarterly EBITDA is higher than 95.09% of companies in Healthcare sector
When is BAX next earnings release?
The next earnings release for BAX is on
TTM EBITDA
$1.73B$133.00M+8.32%
Summary
- Current Value
- As of today, BAX TTM EBITDA is $1.73B, up +8.32% on
- Historical Performance
- BAX TTM EBITDA is up +1.76% year-over-year, and down -42.65% over the past 3 years
- All-Time High Comparison
- BAX TTM EBITDA is currently -55.93% below its historical high of $3.93B set on
- 3-Year Low Comparison
- BAX TTM EBITDA is +11.81% above its 3-year low of $1.55B reached on
- Sector Comparison
- BAX TTM EBITDA is higher than 95.27% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.73B | +8.3% | +1.8% | -42.6% | -36.2% | |
| Annual EBITDA | $1.68B | – | -10.8% | -43.4% | -37.6% | |
| Quarterly EBITDA | $431.00M | -4.7% | +44.6% | -38.9% | -39.8% | |
| Price | $19.73 | -12.0% | -39.8% | -57.1% | -74.3% | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $11.02B | +1.3% | +3.9% | -23.6% | -4.4% | |
| TTM EPS | -$0.52 | -96.3% | -329.4% | +89.0% | -129.6% | |
| $741.00M | +2.8% | -8.6% | -56.9% | -60.9% | ||
| TTM Net Income | -$353.00M | -46.5% | -192.7% | +85.8% | -138.4% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.73B | at high | |
| 3Y | $3.10B | N/A | -44.1% |
| 5Y | $3.11B | -44.4% | |
| All | $3.93B | -55.9% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.55B | N/A | +11.8% |
| 3Y | $1.55B | +11.8% | |
| 5Y | $1.55B | +11.8% | |
| All | -$3.45B | +150.1% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of BAX?
As of today, BAX TTM EBITDA is $1.73B
What is BAX TTM EBITDA most recent change?
BAX TTM EBITDA was up +8.32% on September 30, 2025
What is 1-year change in BAX TTM EBITDA?
BAX TTM EBITDA is up +1.76% year-over-year
How far is BAX TTM EBITDA from its all-time high?
BAX TTM EBITDA is currently -55.93% below its historical high of $3.93B set on December 31, 2011
How does BAX TTM EBITDA rank versus sector peers?
BAX TTM EBITDA is higher than 95.27% of companies in Healthcare sector
When is BAX next earnings release?
The next earnings release for BAX is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- BAX Official Website www.baxter.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/10456/000162828025048897/0001628280-25-048897-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/10456/000162828025007201/0001628280-25-007201-index.htm
- BAX Profile on Yahoo Finance finance.yahoo.com/quote/BAX
- BAX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/bax